The global PET Radioisotope (Radiopharmaceuticals in PET Imaging) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on PET Radioisotope (Radiopharmaceuticals in PET Imaging) competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

PET (Positron Emission Tomography) radioisotopes, also known as radiopharmaceuticals, are compounds containing radioactive isotopes that emit positrons. These radioisotopes are used in PET imaging to visualize and quantify biological processes within the body.

The North American market for PET Radioisotope (Radiopharmaceuticals in PET Imaging) is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for PET Radioisotope (Radiopharmaceuticals in PET Imaging) is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

Major global manufacturers of PET Radioisotope (Radiopharmaceuticals in PET Imaging) include IBA Molecular, GE Healthcare, Siemens Healthineers, Eli Lilly and Company, Mallinckrodt Pharmaceuticals, Blue Earth Diagnostics, ANSTO, ROSATOM, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global PET Radioisotope (Radiopharmaceuticals in PET Imaging) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding PET Radioisotope (Radiopharmaceuticals in PET Imaging). The PET Radioisotope (Radiopharmaceuticals in PET Imaging) market size, estimates, and forecasts are provided in terms of shipments (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global PET Radioisotope (Radiopharmaceuticals in PET Imaging) market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist PET Radioisotope (Radiopharmaceuticals in PET Imaging) manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Report

Report Metric	Details
Report Name	PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market
Segment by Type	11C 13N 150 18F Others
by Application	Medical Imaging Scientific Research
Production by Region	North America Europe China Japan
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	IBA Molecular, GE Healthcare, Siemens Healthineers, Eli Lilly and Company, Mallinckrodt Pharmaceuticals, Blue Earth Diagnostics, ANSTO, ROSATOM
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for PET Radioisotope (Radiopharmaceuticals in PET Imaging) manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines PET Radioisotope (Radiopharmaceuticals in PET Imaging) production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes PET Radioisotope (Radiopharmaceuticals in PET Imaging) consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market report?

Ans: The main players in the PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market are IBA Molecular, GE Healthcare, Siemens Healthineers, Eli Lilly and Company, Mallinckrodt Pharmaceuticals, Blue Earth Diagnostics, ANSTO, ROSATOM

What are the Application segmentation covered in the PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market report?

Ans: The Applications covered in the PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market report are Medical Imaging, Scientific Research

What are the Type segmentation covered in the PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market report?

Ans: The Types covered in the PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market report are 11C, 13N, 150, 18F, Others

1 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Overview

1.1 Product Definition

1.2 PET Radioisotope (Radiopharmaceuticals in PET Imaging) by Type

1.2.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Value Growth Rate Analysis by Type: 2025 vs 2032

1.2.2 11C

1.2.3 13N

1.2.4 150

1.2.5 18F

1.2.6 Others

1.3 PET Radioisotope (Radiopharmaceuticals in PET Imaging) by Application

1.3.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Value Growth Rate Analysis by Application: 2025 vs 2032

1.3.2 Medical Imaging

1.3.3 Scientific Research

1.4 Global Market Growth Prospects

1.4.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Estimates and Forecasts (2021–2032)

1.4.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Capacity Estimates and Forecasts (2021–2032)

1.4.3 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Estimates and Forecasts (2021–2032)

1.4.4 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Average Price Estimates and Forecasts (2021–2032)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share by Manufacturers (2021–2026)

2.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share by Manufacturers (2021–2026)

2.3 Global Key Players of PET Radioisotope (Radiopharmaceuticals in PET Imaging), Industry Ranking, 2024 vs 2025

2.4 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.5 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Manufacturers (2021–2026)

2.6 Global Key Manufacturers of PET Radioisotope (Radiopharmaceuticals in PET Imaging), Manufacturing Footprints and Headquarters

2.7 Global Key Manufacturers of PET Radioisotope (Radiopharmaceuticals in PET Imaging), Product Offerings and Applications

2.8 Global Key Manufacturers of PET Radioisotope (Radiopharmaceuticals in PET Imaging), Date of Entry into the Industry

2.9 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Competitive Situation and Trends

2.9.1 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Concentration Rate

2.9.2 Top 5 and Top 10 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Players Market Share by Revenue

2.10 Mergers & Acquisitions and Expansion

3 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Region

3.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

3.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Region (2021–2032)

3.2.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Region (2021–2026)

3.2.2 Global Forecasted Production Value of PET Radioisotope (Radiopharmaceuticals in PET Imaging) by Region (2027–2032)

3.3 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

3.4 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Volume by Region (2021–2032)

3.4.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Region (2021–2026)

3.4.2 Global Forecasted Production of PET Radioisotope (Radiopharmaceuticals in PET Imaging) by Region (2027–2032)

3.5 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Price Analysis by Region (2021–2026)

3.6 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production, Value, and Year-over-Year Growth

3.6.1 North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Estimates and Forecasts (2021–2032)

3.6.2 Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Estimates and Forecasts (2021–2032)

3.6.3 China PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Estimates and Forecasts (2021–2032)

3.6.4 Japan PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Estimates and Forecasts (2021–2032)

4 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Region

4.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

4.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Region (2021–2032)

4.2.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Region (2021–2026)

4.2.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Forecasted Consumption by Region (2027–2032)

4.3 North America

4.3.1 North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.3.2 North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Country (2021–2032)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.4.2 Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Country (2021–2032)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Growth Rate by Region: 2021 vs 2025 vs 2032

4.5.2 Asia Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Region (2021–2032)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.6.2 Latin America, Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Country (2021–2032)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Type (2021–2032)

5.1.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Type (2021–2026)

5.1.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Type (2027–2032)

5.1.3 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share by Type (2021–2032)

5.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Type (2021–2032)

5.2.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Type (2021–2026)

5.2.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Type (2027–2032)

5.2.3 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share by Type (2021–2032)

5.3 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Price by Type (2021–2032)

6 Segment by Application

6.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Application (2021–2032)

6.1.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Application (2021–2026)

6.1.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Application (2027–2032)

6.1.3 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share by Application (2021–2032)

6.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Application (2021–2032)

6.2.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Application (2021–2026)

6.2.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Application (2027–2032)

6.2.3 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share by Application (2021–2032)

6.3 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Price by Application (2021–2032)

7 Key Companies Profiled

7.1 IBA Molecular

7.1.1 IBA Molecular PET Radioisotope (Radiopharmaceuticals in PET Imaging) Company Information

7.1.2 IBA Molecular PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolio

7.1.3 IBA Molecular PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production, Value, Price, and Gross Margin (2021–2026)

7.1.4 IBA Molecular Main Business and Markets Served

7.1.5 IBA Molecular Recent Developments/Updates

7.2 GE Healthcare

7.2.1 GE Healthcare PET Radioisotope (Radiopharmaceuticals in PET Imaging) Company Information

7.2.2 GE Healthcare PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolio

7.2.3 GE Healthcare PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production, Value, Price, and Gross Margin (2021–2026)

7.2.4 GE Healthcare Main Business and Markets Served

7.2.5 GE Healthcare Recent Developments/Updates

7.3 Siemens Healthineers

7.3.1 Siemens Healthineers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Company Information

7.3.2 Siemens Healthineers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolio

7.3.3 Siemens Healthineers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production, Value, Price, and Gross Margin (2021–2026)

7.3.4 Siemens Healthineers Main Business and Markets Served

7.3.5 Siemens Healthineers Recent Developments/Updates

7.4 Eli Lilly and Company

7.4.1 Eli Lilly and Company PET Radioisotope (Radiopharmaceuticals in PET Imaging) Company Information

7.4.2 Eli Lilly and Company PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolio

7.4.3 Eli Lilly and Company PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production, Value, Price, and Gross Margin (2021–2026)

7.4.4 Eli Lilly and Company Main Business and Markets Served

7.4.5 Eli Lilly and Company Recent Developments/Updates

7.5 Mallinckrodt Pharmaceuticals

7.5.1 Mallinckrodt Pharmaceuticals PET Radioisotope (Radiopharmaceuticals in PET Imaging) Company Information

7.5.2 Mallinckrodt Pharmaceuticals PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolio

7.5.3 Mallinckrodt Pharmaceuticals PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production, Value, Price, and Gross Margin (2021–2026)

7.5.4 Mallinckrodt Pharmaceuticals Main Business and Markets Served

7.5.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates

7.6 Blue Earth Diagnostics

7.6.1 Blue Earth Diagnostics PET Radioisotope (Radiopharmaceuticals in PET Imaging) Company Information

7.6.2 Blue Earth Diagnostics PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolio

7.6.3 Blue Earth Diagnostics PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production, Value, Price, and Gross Margin (2021–2026)

7.6.4 Blue Earth Diagnostics Main Business and Markets Served

7.6.5 Blue Earth Diagnostics Recent Developments/Updates

7.7 ANSTO

7.7.1 ANSTO PET Radioisotope (Radiopharmaceuticals in PET Imaging) Company Information

7.7.2 ANSTO PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolio

7.7.3 ANSTO PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production, Value, Price, and Gross Margin (2021–2026)

7.7.4 ANSTO Main Business and Markets Served

7.7.5 ANSTO Recent Developments/Updates

7.8 ROSATOM

7.8.1 ROSATOM PET Radioisotope (Radiopharmaceuticals in PET Imaging) Company Information

7.8.2 ROSATOM PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolio

7.8.3 ROSATOM PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production, Value, Price, and Gross Margin (2021–2026)

7.8.4 ROSATOM Main Business and Markets Served

7.8.5 ROSATOM Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Industry Chain Analysis

8.2 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Modes and Processes

8.4 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales and Marketing

8.4.1 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Channels

8.4.2 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Distributors

8.5 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Customer Analysis

9 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Dynamics

9.1 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Industry Trends

9.2 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Drivers

9.3 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Challenges

9.4 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Restraints

9.5 Impact of U.S. Tariffs

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

FEATURED COMPANIES

IBA Molecular

GE Healthcare

Siemens Healthineers

Eli Lilly and Company

Mallinckrodt Pharmaceuticals

Blue Earth Diagnostics

ANSTO

Rosatom

List of Tables

Table 1. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Capacity (Tons) by Manufacturers in 2025

Table 4. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Manufacturers (Tons), 2021–2026

Table 5. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share by Manufacturers (2021–2026)

Table 6. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Manufacturers (US$ Million), 2021–2026

Table 7. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Share by Manufacturers (2021–2026)

Table 8. Global Key Players of PET Radioisotope (Radiopharmaceuticals in PET Imaging), Industry Ranking, 2024 vs 2025

Table 9. Classification of Companies by Tier (Tier 1, Tier 2, Tier 3), based on PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value, 2025

Table 10. Global Market PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Manufacturers (US$/Ton), 2021–2026

Table 11. Global Key Manufacturers of PET Radioisotope (Radiopharmaceuticals in PET Imaging), Manufacturing Footprints and Headquarters

Table 12. Global Key Manufacturers of PET Radioisotope (Radiopharmaceuticals in PET Imaging), Product Offerings and Applications

Table 13. Global Key Manufacturers of PET Radioisotope (Radiopharmaceuticals in PET Imaging), Date of Entry into the Industry

Table 14. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Mergers & Acquisitions and Expansion Plans

Table 16. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 17. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value (US$ Million) by Region (2021–2026)

Table 18. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share by Region (2021–2026)

Table 19. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value (US$ Million) Forecast by Region (2027–2032)

Table 20. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share Forecast by Region (2027–2032)

Table 21. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Comparison by Region: 2021 vs 2025 vs 2032 (Tons)

Table 22. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons) by Region (2021–2026)

Table 23. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share by Region (2021–2026)

Table 24. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons) Forecast by Region (2027–2032)

Table 25. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share Forecast by Region (2027–2032)

Table 26. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Average Price (US$/Ton) by Region (2021–2026)

Table 27. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Average Price (US$/Ton) by Region (2027–2032)

Table 28. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (Tons)

Table 29. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Region (Tons), 2021–2026

Table 30. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Market Share by Region (2021–2026)

Table 31. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Forecasted Consumption by Region (Tons), 2027–2032

Table 32. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Forecasted Consumption Market Share by Region (2027–2032)

Table 33. North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)

Table 34. North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Country (Tons), 2021–2026

Table 35. North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Country (Tons), 2027–2032

Table 36. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)

Table 37. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Country (Tons), 2021–2026

Table 38. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Country (Tons), 2027–2032

Table 39. Asia Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (Tons)

Table 40. Asia Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Region (Tons), 2021–2026

Table 41. Asia Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Region (Tons), 2027–2032

Table 42. Latin America, Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)

Table 43. Latin America, Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Country (Tons), 2021–2026

Table 44. Latin America, Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Country (Tons), 2027–2032

Table 45. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons) by Type (2021–2026)

Table 46. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons) by Type (2027–2032)

Table 47. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share by Type (2021–2026)

Table 48. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share by Type (2027–2032)

Table 49. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value (US$ Million) by Type (2021–2026)

Table 50. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value (US$ Million) by Type (2027–2032)

Table 51. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share by Type (2021–2026)

Table 52. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share by Type (2027–2032)

Table 53. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Price (US$/Ton) by Type (2021–2026)

Table 54. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Price (US$/Ton) by Type (2027–2032)

Table 55. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons) by Application (2021–2026)

Table 56. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons) by Application (2027–2032)

Table 57. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share by Application (2021–2026)

Table 58. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share by Application (2027–2032)

Table 59. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value (US$ Million) by Application (2021–2026)

Table 60. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value (US$ Million) by Application (2027–2032)

Table 61. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share by Application (2021–2026)

Table 62. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share by Application (2027–2032)

Table 63. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Price (US$/Ton) by Application (2021–2026)

Table 64. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Price (US$/Ton) by Application (2027–2032)

Table 65. IBA Molecular PET Radioisotope (Radiopharmaceuticals in PET Imaging) Company Information

Table 66. IBA Molecular PET Radioisotope (Radiopharmaceuticals in PET Imaging) Specification and Application

Table 67. IBA Molecular PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 68. IBA Molecular Main Business and Markets Served

Table 69. IBA Molecular Recent Developments/Updates

Table 70. GE Healthcare PET Radioisotope (Radiopharmaceuticals in PET Imaging) Company Information

Table 71. GE Healthcare PET Radioisotope (Radiopharmaceuticals in PET Imaging) Specification and Application

Table 72. GE Healthcare PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 73. GE Healthcare Main Business and Markets Served

Table 74. GE Healthcare Recent Developments/Updates

Table 75. Siemens Healthineers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Company Information

Table 76. Siemens Healthineers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Specification and Application

Table 77. Siemens Healthineers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 78. Siemens Healthineers Main Business and Markets Served

Table 79. Siemens Healthineers Recent Developments/Updates

Table 80. Eli Lilly and Company PET Radioisotope (Radiopharmaceuticals in PET Imaging) Company Information

Table 81. Eli Lilly and Company PET Radioisotope (Radiopharmaceuticals in PET Imaging) Specification and Application

Table 82. Eli Lilly and Company PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 83. Eli Lilly and Company Main Business and Markets Served

Table 84. Eli Lilly and Company Recent Developments/Updates

Table 85. Mallinckrodt Pharmaceuticals PET Radioisotope (Radiopharmaceuticals in PET Imaging) Company Information

Table 86. Mallinckrodt Pharmaceuticals PET Radioisotope (Radiopharmaceuticals in PET Imaging) Specification and Application

Table 87. Mallinckrodt Pharmaceuticals PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 88. Mallinckrodt Pharmaceuticals Main Business and Markets Served

Table 89. Mallinckrodt Pharmaceuticals Recent Developments/Updates

Table 90. Blue Earth Diagnostics PET Radioisotope (Radiopharmaceuticals in PET Imaging) Company Information

Table 91. Blue Earth Diagnostics PET Radioisotope (Radiopharmaceuticals in PET Imaging) Specification and Application

Table 92. Blue Earth Diagnostics PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 93. Blue Earth Diagnostics Main Business and Markets Served

Table 94. Blue Earth Diagnostics Recent Developments/Updates

Table 95. ANSTO PET Radioisotope (Radiopharmaceuticals in PET Imaging) Company Information

Table 96. ANSTO PET Radioisotope (Radiopharmaceuticals in PET Imaging) Specification and Application

Table 97. ANSTO PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 98. ANSTO Main Business and Markets Served

Table 99. ANSTO Recent Developments/Updates

Table 100. ROSATOM PET Radioisotope (Radiopharmaceuticals in PET Imaging) Company Information

Table 101. ROSATOM PET Radioisotope (Radiopharmaceuticals in PET Imaging) Specification and Application

Table 102. ROSATOM PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)

Table 103. ROSATOM Main Business and Markets Served

Table 104. ROSATOM Recent Developments/Updates

Table 105. Key Raw Materials Lists

Table 106. Raw Materials Key Suppliers Lists

Table 107. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Distributors List

Table 108. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Customers List

Table 109. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Trends

Table 110. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Drivers

Table 111. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Challenges

Table 112. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Product Picture of PET Radioisotope (Radiopharmaceuticals in PET Imaging)

Figure 2. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Value by Type (US$ Million), 2021–2032

Figure 3. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Share by Type: 2025 vs 2032

Figure 4. 11C Product Picture

Figure 5. 13N Product Picture

Figure 6. 150 Product Picture

Figure 7. 18F Product Picture

Figure 8. Others Product Picture

Figure 9. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Value by Application (US$ Million), 2021–2032

Figure 10. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Share by Application: 2025 vs 2032

Figure 11. Medical Imaging

Figure 12. Scientific Research

Figure 13. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value (US$ Million), 2021–2032

Figure 15. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Capacity (Tons), 2021–2032

Figure 16. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons), 2021–2032

Figure 17. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price (US$/Ton), 2021–2032

Figure 18. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Report Years Considered

Figure 19. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Share by Manufacturers in 2025

Figure 20. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Share by Manufacturers (2025)

Figure 21. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 22. Top 5 and Top 10 Global Players: Market Share by PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue in 2025

Figure 23. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)

Figure 24. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share by Region: 2021 vs 2025 vs 2032

Figure 25. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Comparison by Region: 2021 vs 2025 vs 2032 (Tons)

Figure 26. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share by Region: 2021 vs 2025 vs 2032

Figure 27. North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value (US$ Million) Growth Rate (2021–2032)

Figure 28. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value (US$ Million) Growth Rate (2021–2032)

Figure 29. China PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value (US$ Million) Growth Rate (2021–2032)

Figure 30. Japan PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value (US$ Million) Growth Rate (2021–2032)

Figure 31. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Region: 2021 vs 2025 vs 2032 (Tons)

Figure 32. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Market Share by Region: 2021 vs 2025 vs 2032

Figure 33. North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (Tons), 2021–2032

Figure 34. North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Market Share by Country (2021–2032)

Figure 35. U.S. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (Tons), 2021–2032

Figure 36. Canada PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (Tons), 2021–2032

Figure 37. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (Tons), 2021–2032

Figure 38. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Market Share by Country (2021–2032)

Figure 39. Germany PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (Tons), 2021–2032

Figure 40. France PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (Tons), 2021–2032

Figure 41. U.K. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (Tons), 2021–2032

Figure 42. Italy PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (Tons), 2021–2032

Figure 43. Russia PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (Tons), 2021–2032

Figure 44. Asia Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (Tons), 2021–2032

Figure 45. Asia Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Market Share by Region (2021–2032)

Figure 46. China PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (Tons), 2021–2032

Figure 47. Japan PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (Tons), 2021–2032

Figure 48. South Korea PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (Tons), 2021–2032

Figure 49. China Taiwan PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (Tons), 2021–2032

Figure 50. Southeast Asia PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (Tons), 2021–2032

Figure 51. India PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (Tons), 2021–2032

Figure 52. Latin America, Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (Tons), 2021–2032

Figure 53. Latin America, Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Market Share by Country (2021–2032)

Figure 54. Mexico PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (Tons), 2021–2032

Figure 55. Brazil PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (Tons), 2021–2032

Figure 56. Turkey PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (Tons), 2021–2032

Figure 57. GCC Countries PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (Tons), 2021–2032

Figure 58. Global Production Market Share of PET Radioisotope (Radiopharmaceuticals in PET Imaging) by Type (2021–2032)

Figure 59. Global Production Value Market Share of PET Radioisotope (Radiopharmaceuticals in PET Imaging) by Type (2021–2032)

Figure 60. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Price (US$/Ton) by Type (2021–2032)

Figure 61. Global Production Market Share of PET Radioisotope (Radiopharmaceuticals in PET Imaging) by Application (2021–2032)

Figure 62. Global Production Value Market Share of PET Radioisotope (Radiopharmaceuticals in PET Imaging) by Application (2021–2032)

Figure 63. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Price (US$/Ton) by Application (2021–2032)

Figure 64. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Value Chain

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global SPECT Radiopharmaceuticals Market Research Report 2025

Global Nuclear Medicine Radiopharmaceuticals Market Research Report 2024

Global Radiopharmaceutical Market Research Report 2025

Global Radiopharmaceuticals in Nuclear Medicine Market Research Report 2025

Global Nuclear Medicine Market Research Report 2025

Global Positron Emission Tomography Devices Market Research Report 2024

Global PET Scanners Market Research Report 2024

Global Radiopharmaceuticals for Diagnosis Market Research Report 2024

Global Radiopharmaceutical Therapy Market Research Report 2025

Global Positron Emission Computed Tomography Market Research Report 2024

Global PET Nuclear Medicine Imaging Market Research Report 2025

Global Therapeutic Radioisotopes Market Insights Forecast to 2030

Global Diagnostic Radioisotopes Market Insights Forecast to 2030

Positron Emission Tomography PET Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Diagnostic Radiopharmaceuticals Market Research Report 2024

Global PET Scan Devices Market Research Report 2024

Global Positron Emission Tomography PET Equipment Market Research Report 2025

Global PET Tracers Market Research Report 2025

Global Therapeutic Radiopharmaceuticals Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions